Cargando…
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs). The former is mainly related to the serotonin secretion by a small bowel NEN, whereas the latter depends on an insulin hypersecretio...
Autores principales: | Spada, Francesca, Rossi, Roberta E., Kara, Elda, Laffi, Alice, Massironi, Sara, Rubino, Manila, Grimaldi, Franco, Bhoori, Sherrie, Fazio, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228616/ https://www.ncbi.nlm.nih.gov/pubmed/34199977 http://dx.doi.org/10.3390/ph14060539 |
Ejemplares similares
-
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022) -
Hyperinsulinemic Hypoglycemia – The Molecular Mechanisms
por: Nessa, Azizun, et al.
Publicado: (2016) -
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
por: Fazio, Nicola, et al.
Publicado: (2021) -
Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)
por: Laffi, Alice, et al.
Publicado: (2023) -
Comment on persistent hyperinsulinemic hypoglycemia of infancy
por: Prashanth, G. P., et al.
Publicado: (2013)